EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Inclusion Criteria: * Histologically confirmed or suspected diagnosis of 1 of the following: * Intra-abdominal malignancy of 1 of the following types: * Sarcoma * Ovarian cancer * Gastrointestinal malignancies, including, but not limited to, appendiceal cancer, colon cancer, or gastric cancer * Non-small cell lung cancer * Planning to undergo surgical resection of disease * Disease has the propensity to spread to the peritoneal cavity (intra-abdominal malignancy patients) * Performance status - ECOG 0-2 * WBC ≥ 2,000/mm\^3 * Platelet count ≥ 100,000/mm\^3 * Bilirubin \< 1.5 mg/dL * Creatinine normal * Creatinine clearance ≥ 60 mL/min * Body weight ≤ 130 kg * No G6PD deficiency * No porphyria * No history of peripheral neuropathy ≥ grade 3 * Able to tolerate anesthesia and major surgery * Not pregnant or nursing * Negative pregnancy test * Fertile patients must use effective contraception during and for 1 month after study participation